SCHEMBL4939233

SCHEMBL4939233

O=C(O)c1ccc2c(c1)CNC2OC(=O)C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
PLA2G2D Q9UNK4 1/20 0.35
KDM4E B2RXH2 2/20 0.34
MAPT P10636 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
SRD5A2 P31213 5/20 0.33
SRD5A1 P18405 3/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA7 P43166 1/20 0.33
TPMT P51580 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
KDM1A O60341 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MRGPRX4 Q96LA9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3875585 0.80 CHRNB2 (0.40) ALDH1A1KDM4EMAPTKDM1ANPSR1
SCHEMBL4237737 0.80 PNMT (0.46) KDM1AMRGPRX4HDAC1HDAC6
SCHEMBL3883765 0.78 KDM4C (0.40) ALDH1A1KDM4EMAPTNPSR1SMN1; SMN2
SCHEMBL29238410 0.76 ALDH1A1 (0.40) ALDH1A1PLA2G2DKDM4EMAPTTDP1
SCHEMBL3875477 0.76 KDM4C (0.39)
SCHEMBL3875445 0.74 GPER1 (0.39)
SCHEMBL3873750 0.74 IDH1 (0.34) HDAC6
SCHEMBL3880392 0.74
Trifluoroacetic Acid SCHEMBL384702 0.73 KDM1A (0.38) ALDH1A1PLA2G2DKDM4ETDP1KDM1A
SCHEMBL4564235 0.71 TDP1 (0.46) ALDH1A1KDM4EMAPTTDP1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1877379-A1 HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90 Astex Therapeutics Limited (GB) 2008-01-16 EP disclosed
WO-2006109085-A1 HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90 ASTEX THERAPEUTICS LIMITED (GB) 2006-10-19 WO disclosed